These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22066792)

  • 1. The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people.
    Milian M; Teufel P; Honegger J; Gallwitz B; Schnauder G; Psaras T
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):861-7. PubMed ID: 22066792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties.
    Milian M; Teufel P; Honegger J; Gallwitz B; Schnauder G; Psaras T
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):851-60. PubMed ID: 21801193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing's disease patients in the course of the disease.
    Milian M; Honegger J; Teufel P; Wolf A; Psaras T
    Neuroendocrinology; 2013; 98(3):188-99. PubMed ID: 24080783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease.
    Milian M; Kreitschmann-Andermahr I; Siegel S; Kleist B; Führer-Sakel D; Honegger J; Buchfelder M; Psaras T
    Neuroendocrinology; 2015; 102(1-2):60-7. PubMed ID: 25968090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related Quality of Life in Patients After Treatment of Cushing's Disease.
    Nader S; Burkhardt T; Vettorazzi E; Milian M; Aberle J; Petersenn S; Flitsch J
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):187-91. PubMed ID: 27008635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of quality of life in 102 patients with treated Cushing's disease.
    Carluccio A; Sundaram NK; Chablani S; Amrock LG; Lambert JK; Post KD; Geer EB
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):404-11. PubMed ID: 24931777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.
    Siegel S; Milian M; Kleist B; Psaras T; Tsiogka M; Führer D; Koltowska-Häggström M; Honegger J; Müller O; Sure U; Menzel C; Buchfelder M; Kreitschmann-Andermahr I
    Pituitary; 2016 Dec; 19(6):590-600. PubMed ID: 27590785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients after long-term biochemical cure of Cushing's disease.
    van Aken MO; Pereira AM; Biermasz NR; van Thiel SW; Hoftijzer HC; Smit JW; Roelfsema F; Lamberts SW; Romijn JA
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3279-86. PubMed ID: 15741267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment.
    Ritvonen E; Karppinen A; Sintonen H; Vehkavaara S; Kivipelto L; Roine RP; Niemelä M; Schalin-Jäntti C
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):412-21. PubMed ID: 25039500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.
    Webb SM; Ware JE; Forsythe A; Yang M; Badia X; Nelson LM; Signorovitch JE; McLeod L; Maldonado M; Zgliczynski W; de Block C; Portocarrero-Ortiz L; Gadelha M
    Eur J Endocrinol; 2014 Jul; 171(1):89-98. PubMed ID: 24760537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.
    Thompson SK; Hayman AV; Ludlam WH; Deveney CW; Loriaux DL; Sheppard BC
    Ann Surg; 2007 May; 245(5):790-4. PubMed ID: 17457173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.
    Valassi E; Feelders R; Maiter D; Chanson P; Yaneva M; Reincke M; Krsek M; Tóth M; Webb SM; Santos A; Paiva I; Komerdus I; Droste M; Tabarin A; Strasburger CJ; Franz H; Trainer PJ; Newell-Price J; Wass JA; Papakokkinou E; Ragnarsson O;
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):787-798. PubMed ID: 29574994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar psychopathological profiles in female and male Cushing's disease patients after treatment but differences in the pathogenesis of symptoms.
    Milian M; Honegger J; Gerlach C; Hemeling X; Psaras T
    Neuroendocrinology; 2014; 100(1):9-16. PubMed ID: 24902887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities and predictors of health-related quality of life in Dravet syndrome.
    Brunklaus A; Dorris L; Zuberi SM
    Epilepsia; 2011 Aug; 52(8):1476-82. PubMed ID: 21668444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Scoliosis Research Society Health-Related Quality of Life (SRS-30) age-gender normative data: an analysis of 1346 adult subjects unaffected by scoliosis.
    Baldus C; Bridwell K; Harrast J; Shaffrey C; Ondra S; Lenke L; Schwab F; Mardjetko S; Glassman S; Edwards C; Lowe T; Horton W; Polly D
    Spine (Phila Pa 1976); 2011 Jun; 36(14):1154-62. PubMed ID: 21289576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing's disease.
    Heald A; Parr C; Gibson C; O'driscoll K; Fowler H
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):490-7. PubMed ID: 17115346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.
    van der Klaauw AA; Kars M; Biermasz NR; Roelfsema F; Dekkers OM; Corssmit EP; van Aken MO; Havekes B; Pereira AM; Pijl H; Smit JW; Romijn JA
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):775-84. PubMed ID: 18462264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of anxiety-associated personality traits in patients with Cushing's disease: a cross-sectional study.
    Dimopoulou C; Ising M; Pfister H; Schopohl J; Stalla GK; Sievers C
    Neuroendocrinology; 2013; 97(2):139-45. PubMed ID: 22572774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-specific quality of life evaluation and its determinants in Cushing's syndrome: what have we learnt?
    Badia X; Valassi E; Roset M; Webb SM
    Pituitary; 2014 Apr; 17(2):187-95. PubMed ID: 23564339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.